Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies.
Phillip J MeaseJoseph Frank MerolaYoshiya TanakaLaure GossecIain B McInnesChristopher T RitchlinRobert B M LandeweAkihiko AsahinaBarbara InkAndrea HeinrichsRajan BajracharyaVishvesh ShendeJason CoarseLaura C CoatesPublished in: Rheumatology and therapy (2024)
BE OPTIMAL (NCT03895203), BE COMPLETE (NCT03896581), BE VITAL (NCT04009499).
Keyphrases